Cellular Therapies

Human Platelet Lysate (HPL)

HPL is frequently requested from Blood Centers either as outdated platelet concentrates or more elaborate products. A review written by members of the WP is available here.

We currently work on the questions of dosing, use of fresh vs outdated platelets, storage conditions and quality control sources or platelets. We encourage exchange between groups and support contacts.

 

Autologous Serum Eye drops

The group of Dr Denese Marks in the Australian Red Cross Blood Service, Sydney has published a review which can be recommended. DOI: 10.1016/j.transci.2015.05.015

Dr Pieter van der Meer and colleagues also published a review in 2016 on SED. DOI: 10.1016/j.transci.2016.01.022

Unproven Cellular Therapies

We consider this as an important topic that transfusionsists should be aware of and have an attitude to. The International Society of Cellular Therapies (ISCT) has published a manuscript containing recommendations which we support (DOI: 10.1016/j.jcyt.2015.10.007).

Biobanking for Therapeutic Purposes

The WP is currently working on defining approaches towards Biobanking, and collecting references for currenty regulatory standards.